Akebia and IRC launch Vafseo for anemia in dialysis patients

Akebia Therapeutics and Innovative Renal Care announce the nationwide availability of Vafseo®️ (vadadustat) across IRC’s more than 230 dialysis clinics. This milestone expands access to an innovative treatment option for anemia due to chronic kidney disease in dialysis patients, supporting our mission of delivering more tomorrows to our patients, their families, and friends. Read the full release: https://lnkd.in/eAQjsC63

  • No alternative text description for this image

To view or add a comment, sign in

Explore content categories